cobas® liat SARS-CoV-2
By Roche Diagnostics · Switzerland

Summary
cobas® liat SARS-CoV-2 is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Registration status and availability vary by market.
Classification
- Category
- Molecular Assays
- Subcategory
- Respiratory PCR Panels
- Product Type
- Assay Kit
- Technology
- Sample-to-Answer
Application
- Application Area
- Respiratory, Emerging Pathogens
- Target Pathogens
- SARS-CoV-2, Influenza, RSV
Workflow
- Sample Types
- Np Swab
Regulatory Status
Reported from manufacturer sources and not independently verified.
Buyer Notes
Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.
Related Test Guides
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
ACT ecolabels are now available for cobas molecular reagents & assays for use on cobas 5800/6800/8800 systems and the cobas liat system and assay portfolio .
SARS-CoV-2, influenza A, influenza B and RSV RNA are generally detectable in nasal swab and nasopharyngeal swab specimens during the acute phase of infection.
The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test is intended for use by trained operators specifically instructed in the use of the cobas liat system and the cobas liat SARS-CoV-2, Inf
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-04
2026-10-06
availability varies
